International Biotechnology Trust’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$30K Hold
10,000
0.01% 65
2023
Q2
$24.7K Hold
10,000
0.01% 61
2023
Q1
$22.5K Hold
10,000
0.01% 64
2022
Q4
$34.9K Hold
10,000
0.01% 63
2022
Q3
$370K Buy
10,000
+9,810
+5,163% +$363K 0.12% 62
2022
Q2
$10K Sell
190
-9,810
-98% -$516K 0.1% 75
2022
Q1
$741K Hold
10,000
0.17% 61
2021
Q4
$225K Hold
10,000
0.05% 71
2021
Q3
$261K Buy
+10,000
New +$261K 0.06% 65